Summary
Cardiovascular disease (CVD) is the leading cause of death and disability for women in the United States. Most of the risk factors for CVD and benefits of risk reduction are similar in women and men with some risk factors varying in magnitude and other risk factors unique in women. Even though heart disease remains the leading cause of mortality in women, healthy life style changes in addition to modification of traditional risk factors for CVD can impact positively on the incidence of CVD. Inspite of known benefits, CVD risk reduction strategies are underused. Prevention and treatment strategies in women need to be more aggressive. The CVD risk factors in women and benefits of risk factor modification are reviewed here.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
American Heart Association. 2001. Heart and Stroke Statistical Update. Dallas,Texas: American Heart Association, 2000.
Winkleby MA, Kraemer HC, Ahn DK, Varady AN. 1998. Ethnic and socioeconomic differences in carediovascular disease risk factors. JAMA 280:356–362.
Wenger NK. 1998. Preventive coronary care in women: The challenge to institute coronary risk reduction. Prev Cardiol 1:25.
Rich-Edwards JW, Manson JE, Hennekens CH, Buring JE. 1995. The primary prevention of coronary heart disease in women. N Engl J Med 332:1758–1766.
Mosca L, Manson JE, Sutherland SE, Langer RD, Manolio T, Barrett-Connor E. 1997. Cardiovascular disease in women: A statement for healthcare professionals from the American Heart Association writing group. Circulation 97:2468–2482.
Mosca L, Grundy SM, Judelson D, King K, Limacher M, Oparil S, Pasternak R, Pearson TA, Redberg RF, Smith SC, Winston M, Zinberg S. 1999. Guide to preventive cardiology for women. Circulation 99:2480–2484.
Douglas PS, Ginburg GS. 1996. The evaluation of chest pain in women. N Engl J Med 344: 1311–1315.
National high blood pressure education program working group: National high blood pressure working group report on high blood pressure in the elderly. 1994. Hypertension 23:275–285.
SHEP Cooperative Research Group. 1991. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 265:3255–3264.
Zuanette G, Lantini R, Maggioni AP, Santoro L, Franzosi MG. 1993. Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 Study. J Am Coll Cardiol 22:1788–1794.
Welty FK. 2001. Cardiovascular disease and dyslipidemia in women. Arch Intern Med 161:514–522.
Tsang TSM, Barnes ME, Gersh BJ, Hayes SN. 2000. Risk of coronary heart disease in women: Current understanding and evolving concepts. Mayo Clin Proc 75:1289–1303.
Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. 2000. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med 343:16–22.
Jousilahti P, Tuomilehto J, Vartiainen E, Pekkanen J, Puskha P. 1996. Body weight, cardiovascular risk factors, and coronary mortality: 15-year follow-up of middle aged men and women in eastern Finland. Circulation 93:1372–1379.
Lee IM, Rexrode KM, Cook NR, Manson JE, Buring JE. 2001. Physical activity and coronary heart disease in women. JAMA 285:1447–1454.
Blair SN, Kohl HW, Paffenbarger RS. 1989. Physical fitness and all-cause mortality: a prospective study of healthy men and women. JAMA 262:2395–2401.
Blakely JA. 2000. The heart and estrogen/progestin replacement study revisited. Arch Intern Med 160:2897–2900.
Goldstein F, Stampfer MJ, Manson JE, Colditz GA, Willett WC, Rosner B, Speizer FE, Hennekens CH. 1996. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 335:453–461.
The Women’s Health Initiative Study Group: Design of the Women’s Health Initiative Clinical Trial and Observational Study. 1998. Control Clin Trials 19:61–109.
Chasan-Taber L, Stampfer MJ. 1998. Epidemiology of oral contraceptives and cardiovascular disease. Ann Intern Med 128:467–477.
Pearson TA. 2002. New tools for coronary risk assessment. Circulation 105:886–892.
Orth-Gomer E, Mittleman MA, Schenck-Gustafsson K, Wamala SP, Eriksson M, Belkic K, Kirkeeide R, Svane B, Ryden L. 1997. Lipoprotein(a) as a determinant of coronary heart disease in young women. Circulation 95:329–334.
Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. 1998. Prospective study of C-Reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98:731–733.
Kromhout D, Menotti A, Kesteloot H, Sans S. 2002. Prevention of coronary heart disease by diet and lifestyle. Circulation 105:893–898.
Robertson RM. 2001. Women and cardiovascular disease. The risk of misperception and the need for action. Circulation 103:2318–2320.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Bhat, G. (2003). Cardiovascular Risk Factors in Women. In: Dhalla, N.S., Chockalingam, A., Berkowitz, H.I., Singal, P.K. (eds) Frontiers in Cardiovascular Health. Progress in Experimental Cardiology, vol 9. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0455-9_31
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0455-9_31
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5085-9
Online ISBN: 978-1-4615-0455-9
eBook Packages: Springer Book Archive